The Limited Times

Now you can see non-English news...

Controversial weed killer: Bayer loses another glyphosate appeal in the US

2021-05-14T22:13:47.076Z

A court in San Francisco upheld a judgment according to which Bayer had to pay a total of 25 million dollars in damages to a cancer patient. It is not the first setback in court for the group.



Enlarge image

Controversial pesticide Roundup (archive picture): acquisition with consequences

Photo: Mike Blake / REUTERS

To get rid of the weeds on his property in Northern California, Edwin Hardeman regularly used Monsanto's Roundup weed killer.

A court in San Francisco has now upheld a ruling according to which the agricultural company Bayer has to pay him a total of a good 25 million dollars in damages.

This means that Bayer is also subject to the second glyphosate appeal in the USA.

Hardeman had blamed the glyphosate-containing weed killer for his cancer and sued the Roundup manufacturer Monsanto, which Bayer acquired in 2018 for 60 billion dollars.

A jury in 2019 initially imposed fines of a good $ 80 million on Bayer.

The amount was later significantly reduced.

The group had appealed anyway.

Bayer is confronted with numerous glyphosate lawsuits in the United States, which the company intends to settle with a settlement worth billions.

So far, only three cases have been heard in courts, and the Dax group lost all three.

Bayer has not yet had any success in appeals.

Bayer did not initially provide a statement.

The glyphosate problem taken over with the Monsanto purchase makes the group difficult to create.

In the United States, more than 125,000 plaintiffs have filed claims for damages.

Bayer wants to take more than eleven billion dollars in hand to settle the mass proceedings.

But an important part of the settlement still requires judicial approval.

An important hearing on this is due on May 19.

mic / dpa-afx

Source: spiegel

All business articles on 2021-05-14

You may like

Business 2021-02-25T08:01:28.849Z

Trends 24h

Latest

© Communities 2019 - Privacy